The D3 dopamine receptor: neurobiology and potential clinical relevance
B Levant - Pharmacological reviews, 1997 - ASPET
Dopamine is a major neurotransmitter in the central nervous system. Receptors for this
catecholamine are of considerable interest, as they are the principal target of drugs employed in …
catecholamine are of considerable interest, as they are the principal target of drugs employed in …
[HTML][HTML] Lipids in psychiatric disorders and preventive medicine
M Schneider, B Levant, M Reichel, E Gulbins… - Neuroscience & …, 2017 - Elsevier
Psychiatric disorders like mood disorders, schizophrenia, or drug addiction affect a sizeable
proportion of the human population and severely compromise quality of life. Therefore, …
proportion of the human population and severely compromise quality of life. Therefore, …
Decreased brain docosahexaenoic acid during development alters dopamine-related behaviors in adult rats that are differentially affected by dietary remediation
B Levant, JD Radel, SE Carlson - Behavioural brain research, 2004 - Elsevier
Docosahexaenoic acid (DHA) is a major component of neuronal membranes. In rats, low
brain levels of DHA during development produce alterations in the mesocortical and …
brain levels of DHA during development produce alterations in the mesocortical and …
N-3 (Omega-3) fatty acids: effects on brain dopamine systems and potential role in the etiology and treatment of neuropsychiatric disorders
M Healy-Stoffel, B Levant - CNS & Neurological Disorders …, 2018 - ingentaconnect.com
Background & Objective: A number of neuropsychiatric disorders, including Parkinson's
disease, schizophrenia, attention deficit hyperactivity disorder, and, to some extent, depression, …
disease, schizophrenia, attention deficit hyperactivity disorder, and, to some extent, depression, …
Molecular Modeling of the Three-Dimensional Structure of Dopamine 3 (D3) Subtype Receptor: Discovery of Novel and Potent D3 Ligands through a Hybrid …
…, X Wu, X Fang, J Min, Z Hu, B Levant… - Journal of medicinal …, 2003 - ACS Publications
The dopamine 3 (D 3 ) subtype receptor has been implicated in several neurological conditions,
and potent and selective D 3 ligands may have therapeutic potential for the treatment of …
and potent and selective D 3 ligands may have therapeutic potential for the treatment of …
Decreased brain docosahexaenoic acid content produces neurobiological effects associated with depression: interactions with reproductive status in female rats
B Levant, MK Ozias, PF Davis, M Winter… - …, 2008 - Elsevier
Decreased tissue levels of docosahexaenoic acid (DHA; 22:6n-3) are implicated in the
etiologies of non-puerperal and postpartum depression. With the aim of determining …
etiologies of non-puerperal and postpartum depression. With the aim of determining …
[HTML][HTML] Impostorism in third-year medical students: an item analysis using the Clance impostor phenomenon scale
B Levant, JA Villwock, AM Manzardo - Perspectives on medical education, 2020 - Springer
Introduction Impostorism, feelings of distrust in one’s abilities and accomplishments despite
evidence to the contrary, is frequent in medical students and negatively affects student …
evidence to the contrary, is frequent in medical students and negatively affects student …
Differential distribution of D3 dopamine receptors in the brains of several mammalian species
B Levant - Brain research, 1998 - Elsevier
The D 3 dopamine receptor has been proposed as a potential target for the treatment of
schizophrenia and drug abuse. This study compares the distribution of D 3 sites in mouse, rat, …
schizophrenia and drug abuse. This study compares the distribution of D 3 sites in mouse, rat, …
[HTML][HTML] Impostorism in American medical students during early clinical training: gender differences and intercorrelating factors
B Levant, JA Villwock, AM Manzardo - International journal of …, 2020 - ncbi.nlm.nih.gov
Objectives This study examined the incidence and severity of impostorism in third-year medical
students as they transitioned from the preclinical to clinical phases of training. Methods A …
students as they transitioned from the preclinical to clinical phases of training. Methods A …
N-3 (omega-3) polyunsaturated Fatty acids in the pathophysiology and treatment of depression: pre-clinical evidence
B Levant - CNS & Neurological Disorders-Drug Targets …, 2013 - ingentaconnect.com
A growing literature suggests the association of low tissue levels and/or dietary intake of n-polyunsaturated
fatty acids (PUFA) with depressive illnesses. Animal studies show that low …
fatty acids (PUFA) with depressive illnesses. Animal studies show that low …